AIDS therapy /

Saved in:
Bibliographic Details
Imprint:Philadelphia : Churchill Livingstone, c1999.
Description:xv, 864 p. : ill. (some col.) ; 29 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/3661962
Hidden Bibliographic Details
Other authors / contributors:Dolin, Raphael.
Masur, Henry.
Saag, Michael S.
ISBN:0443075921
Notes:Includes bibliographical references and index.
Table of Contents:
  • Section I. Diagnosis of HIV Infection
  • Chapter 1. Establishing the Diagnosis of HIV Infection
  • Section II. Antiretroviral Therapy
  • Chapter 2. Zidovudine
  • Chapter 3. Didanosine
  • Chapter 4. Zalcitabine
  • Chapter 5. Stavudine
  • Chapter 6. Lamivudine
  • Chapter 7. Emtricitabine
  • Chapter 8. Abacavir
  • Chapter 9. Delavirdine
  • Chapter 10. Nevirapine
  • Chapter 11. Efavirenz
  • Chapter 12. Saquinavir
  • Chapter 13. Ritonavir
  • Chapter 14. Indinavir
  • Chapter 15. Nelfinavir
  • Chapter 16. Amprenavir
  • Chapter 17. Lopinavir
  • Chapter 18. Tenofovir Disoproxil Fumarate
  • Chapter 19. Inhibitors of HIV Attachment and Fusion
  • Chapter 20. New Drugs in Development
  • Section III. Immune-Based Therapies
  • Chapter 21. General Immune-Based Therapies in the Management of HIV-Infected Patients
  • Chapter 22. Approach to HIV Antigen-Specific Immune Enhancement
  • Section IV. Other Therapies Including Alternative Therapies
  • Chapter 23. Complementary and Alternative Therapies
  • Section V. Strategies for Managing Antiretroviral Therapies
  • Chapter 24. Acute HIV Infection
  • Chapter 25. Occupational and Nonoccupational Exposure Management
  • Chapter 26. HIV Resistance Testing in Clinical Practice
  • Chapter 27. Strategic Use of Antiretroviral Therapy
  • Chapter 28. Managing Pregnant Patients
  • Section VI. Diagnosis, Therapy, and Prevention of Opportunistic Processes
  • Chapter 29. Pneumocystosis
  • Chapter 30. Toxoplasmosis
  • Chapter 31. Cryptosporidium, Isospora, and Cyclospora Infections
  • Chapter 32. Microsporidiosis
  • Chapter 33. Mycobacterium Tuberculosis Infection
  • Chapter 34. Mycobacterium avium Complex and Other Atypical Mycobacterial Infections
  • Chapter 35. Bartonellosis
  • Chapter 36. Cryptococcosis
  • Chapter 37. Histoplasmosis
  • Chapter 38. Coccidioidomycosis
  • Chapter 39. Candidiasis
  • Chapter 40. Mycoses Caused by Moulds
  • Chapter 41. Herpes Simplex Virus Infections
  • Chapter 42. Varicella-Zoster Virus Infections
  • Chapter 43. Cytomegalovirus Disease
  • Chapter 44. Human Herpesvirus-6 and Herpesvirus-7 Infections
  • Chapter 45. Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus
  • Chapter 46. Hepatitis Viruses
  • Chapter 47. Sexually Transmitted Human Papillomavirus Infection
  • Chapter 48. JC Virus Neurologic Infection
  • Chapter 49. Sexually Transmitted Diseases
  • Chapter 50. Kaposi's Sarcoma
  • Chapter 51. Non-Hodgkin's Lymphoma
  • Chapter 52. Primary Care: Daily Management of HIV-Infected Patients
  • Section VII. Approach to Specific Syndromes
  • Chapter 53. Wasting Syndrome
  • Chapter 54. Neurologic Disease
  • Chapter 55. Dermatologic Disease
  • Chapter 56. Oropharyngeal Disease
  • Chapter 57. Ophthalmologic Disease
  • Chapter 58. Hematologic Disease
  • Chapter 59. Cardiac Disease
  • Chapter 60. Repiratory Disease
  • Chapter 61. Renal Disease
  • Chapter 62. Diabetes, Insulin Resistance, Lipid Disorders, and Fat Redistribution Syndromes
  • Chapter 63. Adrenal, Gonadal, and Thyroid Disorders
  • Chapter 64. Diseases of the Esophagus, Stomach, and Bowel
  • Chapter 65. Hepatic and Hepatobiliary Diseases
  • Section VIII. Drug Administration and Interactions
  • Chapter 66. Drug Administration and Interactions
  • Chapter 67. AIDS-Related Medications
  • Appendix A. HIV/AIDS-Related Internet Resources
  • Appendix B. Antiretroviral Adult Dosage Guidelines
  • Index